{
  "prompt": {
    "guidelineId": "cg1116-fetal-heart-monitoring-sampling-pdf",
    "fieldsProcessed": [
      "humanFriendlyName",
      "organisation",
      "yearProduced",
      "summary"
    ],
    "enhancedFields": 4,
    "contentLength": 7813
  },
  "response": "{\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Fetal Heart Monitoring Guidelines for Antenatal and Intrapartum Care\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text provided does not contain a publication year. If you have another guideline text that includes the publication date, please share it, and I can extract the year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Fetal Heart Monitoring Guidelines:** - **Monitoring Methods:** Intermittent auscultation (low-risk pregnancies) or continuous electronic fetal monitoring (CEFM) for high-risk cases (e.g., hypertension, breech presentation). - **Antenatal Monitoring:** Dawes-Redman Criteria apply from 26 weeks; discontinue CTG after 10 minutes if criteria met; obstetric review needed if not met by 60 minutes. - **Intrapartum Monitoring:** Regular CTG review, considering maternal/fetal risk factors. Escalate concerns promptly for abnormal traces. - **Fetal Blood Sampling (FBS):** Consider for pathological CTG if no contraindications (e.g., acute fetal compromise, sepsis, bleeding disorders). Avoid if expedited birth is needed. - **Cord Blood Sampling:** Paired samples recommended for concerning labors or SGA/FGR cases. Analyze promptly; document results. - **Poor CTG Quality:** Troubleshoot transducer issues, reposition, or switch to fetal scalp electrode (FSE). - **Documentation & Storage:** CTG traces must be stored for 25 years. - **Human Factors:** Team communication and clinical context are critical for interpretation. - **Care Analysis (FM800E):** Use antenatally only; requires training. Not diagnostic—supports clinical judgment. *Key: Prioritize patient preferences, clinical context, and timely intervention.*\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "endpoint": "enhanceGuidelineMetadata",
  "timestamp": "2025-06-18T21-42-51",
  "textContent": "AI: DeepSeek (deepseek-chat)\n\nQ: {\n  \"guidelineId\": \"cg1116-fetal-heart-monitoring-sampling-pdf\",\n  \"fieldsProcessed\": [\n    \"humanFriendlyName\",\n    \"organisation\",\n    \"yearProduced\",\n    \"summary\"\n  ],\n  \"enhancedFields\": 4,\n  \"contentLength\": 7813\n}\n\nA: {\n  \"success\": true,\n  \"enhancedFields\": [\n    {\n      \"field\": \"humanFriendlyName\",\n      \"oldValue\": null,\n      \"newValue\": \"Fetal Heart Monitoring Guidelines for Antenatal and Intrapartum Care\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"organisation\",\n      \"oldValue\": null,\n      \"newValue\": \"RCOG\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"yearProduced\",\n      \"oldValue\": null,\n      \"newValue\": \"The text provided does not contain a publication year. If you have another guideline text that includes the publication date, please share it, and I can extract the year for you\",\n      \"action\": \"added\"\n    },\n    {\n      \"field\": \"summary\",\n      \"oldValue\": null,\n      \"newValue\": \"**Summary of Fetal Heart Monitoring Guidelines:** - **Monitoring Methods:** Intermittent auscultation (low-risk pregnancies) or continuous electronic fetal monitoring (CEFM) for high-risk cases (e.g., hypertension, breech presentation). - **Antenatal Monitoring:** Dawes-Redman Criteria apply from 26 weeks; discontinue CTG after 10 minutes if criteria met; obstetric review needed if not met by 60 minutes. - **Intrapartum Monitoring:** Regular CTG review, considering maternal/fetal risk factors. Escalate concerns promptly for abnormal traces. - **Fetal Blood Sampling (FBS):** Consider for pathological CTG if no contraindications (e.g., acute fetal compromise, sepsis, bleeding disorders). Avoid if expedited birth is needed. - **Cord Blood Sampling:** Paired samples recommended for concerning labors or SGA/FGR cases. Analyze promptly; document results. - **Poor CTG Quality:** Troubleshoot transducer issues, reposition, or switch to fetal scalp electrode (FSE). - **Documentation & Storage:** CTG traces must be stored for 25 years. - **Human Factors:** Team communication and clinical context are critical for interpretation. - **Care Analysis (FM800E):** Use antenatally only; requires training. Not diagnostic—supports clinical judgment. *Key: Prioritize patient preferences, clinical context, and timely intervention.*\",\n      \"action\": \"added\"\n    }\n  ]\n}",
  "ai_provider": "DeepSeek",
  "ai_model": "deepseek-chat",
  "token_usage": null
}